HighTower Advisors’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$439K Buy
+7,480
New +$314K ﹤0.01% 2865
2025
Q1
Sell
-16,630
Closed -$659K 4064
2024
Q4
$659K Buy
16,630
+305
+2% +$11.5K ﹤0.01% 2264
2024
Q3
$554K Buy
+16,325
New +$459K ﹤0.01% 2328
2019
Q2
Sell
-17,400
Closed -$435K 2518
2019
Q1
$435K Buy
+17,400
New +$332K ﹤0.01% 1530
2015
Q2
Sell
-10,937
Closed -$80K 1726
2015
Q1
$80K Hold
10,937
﹤0.01% 1513
2014
Q4
$106K Hold
10,937
﹤0.01% 1472
2014
Q3
$107K Hold
10,937
﹤0.01% 1429
2014
Q2
$187K Buy
+10,937
New +$157K ﹤0.01% 1417

Other funds holding VCYT

HighTower Advisors's VCYT Position: Q2 2026 in Review

HighTower Advisors opened a new position in Veracyte (VCYT) in Q2 2026: 7,480 shares worth $439K. The stake represents ﹤0.01% of the portfolio and ranks #2865 among its holdings. This is a return to the name: HighTower Advisors previously reported a position in VCYT as recently as Q4 2024.

HighTower Advisors first reported a position in VCYT in Q2 2014 and has held it in 8 quarters since. The position peaked at $659K in Q4 2024. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • HighTower Advisors held 7,480 shares of Veracyte worth $439K as of Q2 2026.
  • Veracyte was a new HighTower Advisors position in Q2 2026.
  • Veracyte made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #2865 holding.
  • HighTower Advisors first reported a position in Veracyte in Q2 2014 and has held it in 8 quarters since.
  • HighTower Advisors's Veracyte position peaked at $659K in Q4 2024.
  • 371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.